NEW YORK (GenomeWeb News) - Nanogen today said that Fisher HealthCare will exclusively distribute its MGB Alert real-time PCR products in the US.
 
Fisher HealthCare, a unit of Fisher Scientific International, will have exclusive rights to sell and distribute the products to clinical laboratories. The products will retain the Nanogen MGB Alert brand and Nanogen’s technical support will continue supporting them.
 
Customers will have access to Nanogen products through Fisher in September, said Nanogen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.